About Conference


Dear Participants On behalf of the Organizing Committee as well as the Program Committee, we are pleased to invite you to the 2022 KoNECT-MOHW-MFDS International Conference(2022 KIC), co-hosted by Ministry of Health and Welfare and Ministry of Food and Drug Safety. We’re pleased to notice that 2022 KIC will return in-person after 2 years of virtual evens.

As a one-of-a-kind conference on clinical trials and new drug development in Asia, this year’s conference is more special than ever. While ensuring the same amazing lecture and presentation quality.

With our partnership, the three-day-long program will include 5 plenary lectures, 1 plenary Talk show, 2 plenary sessions and 18 sessions addressing the most relevant and applicable topics pertaining to new technologies and approaches in new medicine development including regulatory science, real-world studies, data-driven approaches, and patient-centric approaches in 3 parallel tracks-Healthcare Discovery, Clinical Development, and Commercial. In particular, our sessions on advanced regenerative medicine, bio-pharmaceuticals and DTx & Metaverse will allow for in-depth discussion on how to broaden patients’ access to new medicine.

We would like to thank all the members of the Conference Program Committee for their excellent work in ensuring the high quality of the conference program. My special thanks go to MOHW and MFDS for advancing its mission of public health through this collaboration.

We hope that your 2022 KIC experience very stimulating and rewarding.

We wish all the participants to enjoy the 8th KoNECT International Conference.


Bae Byoungjun Byoungjun Bae, MPA, PhD President of KoNECT Organizing Committee Chair, 2022 KoNECT-MOHW-MFDS International Conference